Concepedia

Diana F. Lázaro

DF

23

Publications

1.8K

Citations

18

H-Index

2014

Active since

Affiliations

Max Planck Institute of Experimental Medicine(Current)

Universitätsmedizin Göttingen

University of Göttingen

Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103

Newcastle University

Diana F. Lázaro is an author at Max Planck Institute of Experimental Medicine specializing in medicine, molecular biology, and neurodegenerative diseases.

ORCID

Top concepts

Publications per year

2014–2022

23

Publications

23

Glyoxal as an alternative fixative to formaldehyde in immunostaining and super‐resolution microscopy

Katharina N. Richter, Natalia H. Revelo, Katharina J. Seitz et al. · The EMBO Journal · 2017 · 323 citations · Full text

Systematic Comparison of the Effects of Alpha-synuclein Mutations on Its Oligomerization and Aggregation

Diana F. Lázaro, Eva Rodrigues, Ramona Langohr et al. · PLoS Genetics · 2014 · 236 citations · Full text

, , +17

Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons

Jordi Pujols, Samuel Peña‐Díaz, Diana F. Lázaro et al. · Proceedings of the National Academy of Sciences · 2018 · 224 citations · Full text

The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease

Rita Machado de Oliveira, Hugo Vicente Miranda, Laetitia Francelle et al. · PLoS Biology · 2017 · 212 citations · Full text

, , +18

Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells

Rita Perfeito, Diana F. Lázaro, Tiago F. Outeiro et al. · Molecular and Cellular Neuroscience · 2014 · 99 citations

, , +11

Rows per page

1–5 of 23